Thuy-Hien Thi Doan

Thuy-Hien Thi Doan

Auto-generated profile, based on publicly available information

Thuy-Hien Thi Doan

Can Tho University of Medicine and Pharmacy, lecturer

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2026 in Journal of Chemical Metrology
Verified
Journal Article
Closed access
LNLan Ngoc Chi Nguyen
Lan Ngoc Chi Nguyen
QPQuoc Binh Pham
Quoc Binh Pham
NHNgan Nguyen Hoang
Ngan Nguyen Hoang
HLHoang Minh Le
Hoang Minh Le
TDThuy-Hien Thi Doan
Thuy-Hien Thi Doan
Glucopento decoction, a traditional Vietnamese medicine (VTM) formula, is composed of Gymnema sylvestre, Scrophularia nodosa, Physalis angulata, Gymnanthemum amygdalinum, and Oroxylum indicum, and has long been used as supportive therapy for type 2 diabetes mellitus (T2DM), though its active constituents have remain unclear. This study performs, an ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC–QTOF-MS/MS) method for both positive and negative ion modes was established to investigate the major constituents in Glucopento decoction. Purospher® STAR RP-18 (150 mm x 4,6 mm, 3 µm) column was employed for chromatographic separation, with acetonitrile and 0.1% aqueous formic acid (v/v) as the mobile phase. A total of twenty-seven compounds, including flavonoids and their glycosides, coumarins, triterpenoid saponins, iridoid and phenylethanoid glycosides, withanolides/physalins, terpenoids, and alkaloids, were tentatively characterized based on accurate mass measurement and MS/MS fragmentation behavior. Furthermore literature mining further indicated that more than half of these constituents possess documented antidiabetic or hypoglycemic activities in vitro and in vivo. These results provide a comprehensive phytochemical profile of Glucopento decoction, offering a basis for elucidating its pharmacological mechanisms and supporting its further development as a safe adjunct therapy against type 2 diabetes.